Oxazepam Aurobindo

Oxazepam, the active ingredient in Oxazepam Aurobindo, is a benzodiazepine presented as a oral tablet for systemic use. It is primarily prescribed for the short‑term management of anxiety disorders and related conditions in adults. GNH USA supplies Oxazepam Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oxazepam Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxazepam is a benzodiazepine that acts on the central nervous system to relieve anxiety‑related conditions. - Anxiety disorder: reduces excessive worry and tension in adult patients. - Alcohol withdrawal: alleviates tremor, agitation and risk of seizures during detoxification. - Acute insomnia related to anxiety: promotes sleep onset when anxiety is a contributing factor.

Oxazepam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: light‑headed sensation, especially when standing quickly. - Headache: mild to moderate head pain. - Impaired coordination: reduced motor control or clumsiness. - Gastrointestinal discomfort: nausea, upset stomach or constipation.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, particularly at high doses or with other depressants. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts or aggressive behaviour. - Paradoxical reactions: increased anxiety, agitation or seizures. - Dependence and withdrawal: physical dependence with withdrawal symptoms on abrupt discontinuation.

When using Oxazepam, several safety considerations should be observed. - Assess patient history: review for prior benzodiazepine use, substance abuse, or respiratory disorders. - Avoid alcohol: concurrent consumption can intensify sedation and respiratory depression. - Monitor elderly: increased sensitivity and risk of falls; dose may need adjustment. - Caution in hepatic impairment: metabolism may be reduced, requiring careful dosing. - Pregnancy and lactation: use only if clearly needed, after risk‑benefit evaluation. - Store at ambient temperature: keep below 25°C, in the original container, protected from moisture and light.

Oxazepam can interact with several other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Opioids: combined use can cause profound respiratory depression and profound sedation. - Other benzodiazepines: additive central nervous system depression increasing overdose risk. - Barbiturates: synergistic depressant effects may lead to severe CNS depression.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase serotonergic activity and risk of serotonin syndrome. - Antihistamines: can enhance drowsiness and impair coordination. - Anticonvulsants (e.g., carbamazepine): may reduce oxazepam plasma levels, decreasing effectiveness.